Company intelligence / Profile preview
Vektor Pharma TF
- Ownership
- Private
- Employees
- ~26
- Development stage
- Other
Overview
Vektor Pharma TF develops and manufactures transdermal patches, therapeutic films and oral dissolvable films for generic and new active substances. Multiple transdermal systems have successfully passed pilot pharmacokinetic studies and the company holds a GMP manufacturing permit for clinical studies and narcotics handling, supporting both its own products and contract development/manufacturing activities.[1][3]
- Therapeutic areas
- Neurology
- Modalities
- Transdermal systemTherapeutic filmOral dissolvable filmDevice
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Vektor Pharma TF.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vektor Pharma TF.